ClinConnect ClinConnect Logo
Search / Trial NCT06905535

Corrected Carotid Flow Time for Predicting Spinal Anesthesia-induced Hypotension

Launched by SELCUK UNIVERSITY · Mar 25, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Spinal Anesthesia Induced Hypotension Carotid Flow Time

ClinConnect Summary

This clinical trial is studying how to better predict low blood pressure (hypotension) that can happen during spinal anesthesia in pregnant women undergoing a cesarean section. Spinal anesthesia is a common method used for these surgeries, but it can sometimes cause problems like nausea and dizziness for the mother and can affect the baby as well. The researchers are looking at a technique called carotid artery Doppler, which measures blood flow in the neck, to see if it can help identify women who are at higher risk for low blood pressure after receiving spinal anesthesia.

To participate in this trial, women must be in their third trimester of a full-term pregnancy and have an overall good health status. However, those with certain medical conditions such as high blood pressure, diabetes, or heart problems, or who need an emergency cesarean section, will not be eligible. If you join the study, you can expect to have your blood flow measured and monitored during the procedure to help improve safety for you and your baby. This research aims to enhance our understanding of how to manage low blood pressure during cesarean sections, ultimately leading to better care for mothers and their newborns.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Full-term pregnancy
  • physical status II of American Society of Anesthesiologists
  • Exclusion Criteria:
  • emergency cesarean section,
  • cesarean under general anesthesia
  • gestational Diabetes Mellitus
  • gestational Hypertension
  • preeclampsia,
  • cardiovascular disease
  • cerebrovascular disease
  • chronic kidney disease disease

About Selcuk University

Selçuk University is a prominent educational institution located in Turkey, recognized for its commitment to advancing medical research and clinical studies. As a clinical trial sponsor, Selçuk University leverages its extensive academic resources and expertise to conduct innovative research that aims to address significant healthcare challenges. The university fosters collaboration among researchers, healthcare professionals, and industry partners to facilitate the development of new therapies and improve patient outcomes. Through rigorous adherence to ethical standards and regulatory guidelines, Selçuk University strives to contribute to scientific knowledge and enhance the quality of care within the community and beyond.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported